About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5009321
Allelic
Composition
Men1tm1Zqw/Men1+
Genetic
Background
involves: 129/Sv * 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Men1tm1Zqw mutation (2 available); any Men1 mutation (11 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
tumorigenesis
• gastrointestinal lesions were seen in 8/49 heterozygous mice, mainly situated in the duodenum or at the junction of the glandular stomach and duodenum (J:85302)
• histological examination of gastrointestinal lesions revealed adenomas and carcinomas in the duodenum (J:85302)
• gastrointestinal lesions were seen in 8/49 heterozygous mice, mainly situated in the duodenum or at the junction of the glandular stomach and duodenum (J:85302)
• histological examination of gastrointestinal lesions revealed adenomas and carcinomas in the duodenum (J:85302)
• histological examination of gastrointestinal lesions revealed adenomas in the duodenum (J:85302)
• gastrinomas in the duodenum (J:85302)
• histological examination of gastrointestinal lesions revealed adenomas in the duodenum (J:85302)
• gastrinomas in the duodenum (J:85302)
• histological examination of gastrointestinal lesions revealed adenomas and carcinomas in the glandular stomach (J:85302)
• tumors located in the mucosa of the bodyfunds glandular stomach were composed of uniform cells with scanty cytoplasma and invaded the submucosa layer (J:85302)
• gastrinomas in the glandular stomach (J:85302)
• histological examination of gastrointestinal lesions revealed adenomas and carcinomas in the glandular stomach (J:85302)
• tumors located in the mucosa of the bodyfunds glandular stomach were composed of uniform cells with scanty cytoplasma and invaded the submucosa layer (J:85302)
• gastrinomas in the glandular stomach (J:85302)
• in heterozygous mice older than 13 months of age, a high incidence of multiple endocrine tumors was noted, and nearly all mice developed more than one endocrine tumor (J:85302)
• in heterozygous mice older than 13 months of age, a high incidence of multiple endocrine tumors was noted, and nearly all mice developed more than one endocrine tumor (J:85302)
• adenomas are first seen at 12 months of age and were detected in 7/17 (41%) heterozygous mice in the 13- to 18-month age group and 21/33 (64%) mice over 19 months (J:85302)
• adenomas are first seen at 12 months of age and were detected in 7/17 (41%) heterozygous mice in the 13- to 18-month age group and 21/33 (64%) mice over 19 months (J:85302)
• histological analysis of 23 glands in homozygous mice showed nodular hyperplasia in two (9%) at 8-12 months of age (J:85302)
• at 13-18 months of age, 7/31 (23%) homozygous mice exhibited nodular hyperplasia (J:85302)
• histological analysis of 23 glands in homozygous mice showed nodular hyperplasia in two (9%) at 8-12 months of age (J:85302)
• at 13-18 months of age, 7/31 (23%) homozygous mice exhibited nodular hyperplasia (J:85302)
• histological analysis of 23 glands in homozygous mice showed adenomas in three (13%) at 8-12 months of age (J:85302)
• at 13-18 months of age, 4/31 (13%) heterozygous mice developed adrenal adenomas (J:85302)
• histological analysis of 23 glands in homozygous mice showed adenomas in three (13%) at 8-12 months of age (J:85302)
• at 13-18 months of age, 4/31 (13%) heterozygous mice developed adrenal adenomas (J:85302)
• after 18 months, heterozygous mice developed adenomas in the adrenal cortex (J:85302)
• after 18 months, heterozygous mice developed adenomas in the adrenal cortex (J:85302)
• after 18 months, 28/61 (46%) heterozygous mice developed adenomas or carcinomas in the adrenal cortex (J:85302)
• after 18 months, 28/61 (46%) heterozygous mice developed adenomas or carcinomas in the adrenal cortex (J:85302)
• 3/36 heterozygous female mice over 18 months of age exhibited mammary gland carcinomas (J:85302)
• 3/36 heterozygous female mice over 18 months of age exhibited mammary gland carcinomas (J:85302)
• islet hyperplasia is seen by eight months of age (J:85302)
• at 8-12 months of age, 15 of 23 (65%) mice contained hyperplastic or dysplastic islets (J:85302)
• in 4/12 islet tumors analyzed, two hormones were expresssed simultaneously, such as insulin and glucagon, or glucagon and gastrin, suggesting a mixed hormone production (J:85302)
• islet hyperplasia is seen by eight months of age (J:85302)
• at 8-12 months of age, 15 of 23 (65%) mice contained hyperplastic or dysplastic islets (J:85302)
• in 4/12 islet tumors analyzed, two hormones were expresssed simultaneously, such as insulin and glucagon, or glucagon and gastrin, suggesting a mixed hormone production (J:85302)
• at 8-12 months of age, 5/23 (22%) developed islet adenomas (J:85302)
• at 8-12 months of age, 5/23 (22%) developed islet adenomas (J:85302)
• islet tumors in 6/12 mice showed strong glucagon immunoreactivity, showing alpha-cell tumors or glucagonomas (J:85302)
• islet tumors in 6/12 mice showed strong glucagon immunoreactivity, showing alpha-cell tumors or glucagonomas (J:85302)
• the majority of the islet tumors expressed high levels of insulin and were thus identified as beta-cell insulinomas (J:85302)
• the majority of the islet tumors expressed high levels of insulin and were thus identified as beta-cell insulinomas (J:85302)
• at 8-12 months of age, 2/23 developed (9%) carcinomas (J:85302)
• 13/34 mice develop islet carcinomas at 13-18 months of age (J:85302)
• at 8-12 months of age, 2/23 developed (9%) carcinomas (J:85302)
• 13/34 mice develop islet carcinomas at 13-18 months of age (J:85302)
• pituitary tumors occur after the age of 18 months and are more common in females (79%) (J:85302)
• 6/15 pituitary tumors showed strong GH immunoreactivity (J:85302)
• however, all pituitary tumors were negative for ACTH staining (J:85302)
• pituitary tumors occur after the age of 18 months and are more common in females (79%) (J:85302)
• 6/15 pituitary tumors showed strong GH immunoreactivity (J:85302)
• however, all pituitary tumors were negative for ACTH staining (J:85302)
• 9/15 pituitary tumors showed strong exclusive PRL immunoreactivity (J:85302)
• 9/15 pituitary tumors showed strong exclusive PRL immunoreactivity (J:85302)
• seen in 4/61 heterozygous mice (J:85302)
• seen in 4/61 heterozygous mice (J:85302)
• thyroid follicular cell hyperplasia localized focally, and solid follicular cell carcinomas contained tumor cells in densely packed nest and forming a few minute follicles (J:85302)
• thyroid follicular cell hyperplasia localized focally, and solid follicular cell carcinomas contained tumor cells in densely packed nest and forming a few minute follicles (J:85302)
• heterozygous mutant mice developed a high frequency of tumors in the gonad (J:85302)
• 9/12 (75%) male heterozygous mice at 8-12 months of age exhibited gonadal stromal hyperplasia or dysplasia and 3/12 (25%) exhibited stromal cell tumors, with the tumor incidence reaching 59% and 88% in the 13- to 18-month and 19- to 26-month age groups,espectively (J:85302)
• heterozygous mutant mice developed a high frequency of tumors in the gonad (J:85302)
• 9/12 (75%) male heterozygous mice at 8-12 months of age exhibited gonadal stromal hyperplasia or dysplasia and 3/12 (25%) exhibited stromal cell tumors, with the tumor incidence reaching 59% and 88% in the 13- to 18-month and 19- to 26-month age groups,espectively (J:85302)
• 19/44 (43%) of heterozygous females developed ovarian tumors between the ages of 13 and 26 months (J:85302)
• histological analysis of these tumors revealed that all were derived from sex-cord stromal cells, mainly granulosa cells, contained large round nuclei; the follicular structure was largely replaced by the tumor mass, and tumor cells expressed high levels of 3beta-HSD, indicating steroidogenesis in the tumor cells (J:85302)
• 19/44 (43%) of heterozygous females developed ovarian tumors between the ages of 13 and 26 months (J:85302)
• histological analysis of these tumors revealed that all were derived from sex-cord stromal cells, mainly granulosa cells, contained large round nuclei; the follicular structure was largely replaced by the tumor mass, and tumor cells expressed high levels of 3beta-HSD, indicating steroidogenesis in the tumor cells (J:85302)
• the focal stromal hyperplasia and multinodular tumors were seen and were frequently bilateral, compressed the surrounding seminiferous tubules, resulting in degenerative changes (J:85302)
• testis tumor cells were large and often polygonal, with an abundant granular eosinophilic cytoplasm and a central round nucleus, and occasionally contained lipid pigment and vacuoles (J:85302)
• the focal stromal hyperplasia and multinodular tumors were seen and were frequently bilateral, compressed the surrounding seminiferous tubules, resulting in degenerative changes (J:85302)
• testis tumor cells were large and often polygonal, with an abundant granular eosinophilic cytoplasm and a central round nucleus, and occasionally contained lipid pigment and vacuoles (J:85302)
• testes of heterozygous mice contained hyperplastic stromal cells and tumors, both with strong 3beta-HSD expression, a marker for Leydig cells (J:85302)
• testes of heterozygous mice contained hyperplastic stromal cells and tumors, both with strong 3beta-HSD expression, a marker for Leydig cells (J:85302)

endocrine/exocrine glands
• an enlargement of adrenal glands, often bilateral, is observed in heterozygous mice (J:85302)
• an enlargement of adrenal glands, often bilateral, is observed in heterozygous mice (J:85302)
• enlarged pituitary was often found in heterozygous mice beyond 13 months of age (J:85302)
• enlarged pituitary was often found in heterozygous mice beyond 13 months of age (J:85302)
• seen in 4/61 heterozygous mice (J:85302)
• seen in 4/61 heterozygous mice (J:85302)
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)

nervous system
• enlarged pituitary was often found in heterozygous mice beyond 13 months of age (J:85302)
• enlarged pituitary was often found in heterozygous mice beyond 13 months of age (J:85302)

reproductive system
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)
• a marked increase in ovarian size in heterozygous mice after 13 months of age (J:85302)


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory